Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability

This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University


  • Procedure: Improving the scientific process of human cell reprogramming


Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders
such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian

Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin
biopsy sample due to skin condition in the underarm area.

Ages Eligible for Study

1 Year - 75 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Tasha Kalista

Pediatric Trials